These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32682400)

  • 1. The prognostic values of m6A RNA methylation regulators in uveal melanoma.
    Tang J; Wan Q; Lu J
    BMC Cancer; 2020 Jul; 20(1):674. PubMed ID: 32682400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel four‑snoRNA signature for predicting the survival of patients with uveal melanoma.
    Yi Q; Zou WJ
    Mol Med Rep; 2019 Feb; 19(2):1294-1301. PubMed ID: 30569172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.
    Wan Q; Sang X; Jin L; Wang Z
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N
    Wang T; Bai J; Zhang Y; Xue Y; Peng Q
    Front Immunol; 2022; 13():918522. PubMed ID: 36003405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
    Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
    Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.
    Xia F; Yu Z; Deng A; Gao G
    Exp Biol Med (Maywood); 2022 Feb; 247(3):246-262. PubMed ID: 34743576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
    Miao C; Fang X; Chen Y; Zhao Y; Guo Q
    Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analyses identify potential prognostic markers for uveal melanoma.
    Ni Y; Zhang Z; Chen G; Long W; Tong L; Zeng J
    Exp Eye Res; 2019 Oct; 187():107780. PubMed ID: 31469983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma.
    Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y
    Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma.
    Tang Z; Cai K
    Anal Cell Pathol (Amst); 2021; 2021():6693219. PubMed ID: 34434692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
    Liu Z; Yu L; Lai J; Zhang R
    Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.
    Deng M; Fang L; Li SH; Zhao RC; Mei J; Zou JW; Wei W; Guo RP
    Mutagenesis; 2021 Oct; 36(5):369-379. PubMed ID: 34467992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.